Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Getting a diagnosis

Topic: Risk, prevention and care in population studies

Plain-language summary

<0.001), with key domain correlations ≥0.7 (language, memory, executive). In the pooled sample, covariate-adjusted receiver operating characteristic area under the curves (AUCs) for the SCST composite ranged from 0.854 (cognitively unimpaired [CU] vs. mild cognitive impairment [MCI]) to 0.980 (CU vs. dementia); AUC for CU vs. cognitively impaired [CI] was 0.903. SCST-based classification sensitivity was 0.859 (CU vs. CI), 0.984 (CU vs. dementia), 0.758 (CU vs. MCI), 0.896 (MCI vs. dementia), and 0.882 (no dementia vs. dementia). These findings support the SCST's clinical utility; further studies in broader community-based cohorts are warranted to confirm generalizability.

What this study adds

Evidence grade: Moderate

This is a cross-sectional study of 639 participants. This cross-sectional study found the tablet-based Seoul Cognitive Status Test showed good diagnostic accuracy for distinguishing cognitively unimpaired people from those with mild cognitive impairment or dementia. The authors state further studies in broader community-based cohorts are needed to confirm generalisability; it concerns assessment, not treatment or cure.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Kim, Y. J., Shin, J. S., An, D., Na, D. L., & Kim, H. J. (2025). Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment. Dementia and Neurocognitive Disorders. https://doi.org/10.12779/dnd.2025.24.4.286

Vancouver

Kim YJ, Shin JS, An D, Na DL, Kim HJ. Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment. Dementia and Neurocognitive Disorders. 2025. doi:10.12779/dnd.2025.24.4.286. PMID: 41220867.

BibTeX

@article{kim2025-41220867,
  author  = {Kim, Young Ju and Shin, Joon Soo and An, Dayeong and Na, Duk Lyul and Kim, Hee Jin},
  title   = {{Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment}},
  journal = {Dementia and Neurocognitive Disorders},
  year    = {2025},
  doi     = {10.12779/dnd.2025.24.4.286},
  pmid    = {41220867},
  url     = {https://doi.org/10.12779/dnd.2025.24.4.286}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This cross-sectional study found the tablet-based Seoul Cognitive Status Test showed good diagnostic accuracy for distinguishing cognitively unimpaired people from those with mild cognitive impairment or dementia. The authors state further studies in broader community-based cohorts are needed to confirm generalisability; it concerns assessment, not treatment or cure.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Dementia and Neurocognitive Disorders)
Journal's citation record 0 / 4 Dementia and Neurocognitive Disorders: journal h-index 25 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 639 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Hee Jin Kim: h-index 41 (OpenAlex, whole career)
Institution's track record 1 / 3 Sungkyunkwan University: institution h-index 788 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41220867)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Getting a diagnosis from nearby years

Also tagged “mini-mental”

840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →